ArticleDigital health

Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study.

Melissa L Santorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.